title: Hemophilia A treatment: disruptive technology ahead.
abstract: In this issue of Blood, Uchida et al report the first-in-human use of a new nonsubstitutive therapy for hemophilia A that can potentially be disruptive to the way hemophilia is treated.
authors.affiliation: UNIVERSITY OF SHEFFIELD.
authors.forename: Michael
authors.identifier: http://orcid.org/0000-0001-7622-7939
authors.initials: M
authors.lastname: Makris
mesh_terms: D018033:Antibodies, Bispecific / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D006801:Humans; D008297:Male
chemical_list: D018033:Antibodies, Bispecific; D061067:Antibodies, Monoclonal, Humanized